BCL2L1 and cancer: Furthermore, increased NF-κB activity is associated with enhanced cancer cell survival, by inhibiting apoptosis in breast and pancreatic cancer [39]-[40], through transcriptional regulation of anti-apoptotic proteins (IAPs, FLIP, and Bcl-XL) and cyclin D1 [41].